Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Consensus regarding multiple day and rescue antiemetic therapy

P H De Mulder1, F Roila, M G Kris

  • 1Department of Medical Oncology, University Hospital Nijmegen, The Netherlands.

Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|June 18, 1998
PubMed
Summary

This study reviews effective antiemetic therapies for cancer chemotherapy, focusing on treatments administered over multiple days. It covers both preventative and rescue antiemetic strategies for managing chemotherapy-induced nausea and vomiting.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Global advances and future directions in lung cancer care: expert consensus and strategic priorities.

ESMO open·2026
Same author

Identifying the genomic landscape of EGFR-mutant lung cancers with central nervous system metastases.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Deciphering radiological stable disease to immune checkpoint inhibitors.

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

Upfront pembrolizumab as an effective treatment start in patients with PD-L1 ≥ 50% non-oncogene addicted non-small cell lung cancer and asymptomatic brain metastases: an exploratory analysis.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2021
Same author

COVID-19 in patients with lung cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same author

Cancer-related fatigue: ESMO Clinical Practice Guidelines for diagnosis and treatment.

Annals of oncology : official journal of the European Society for Medical Oncology·2020

Area of Science:

  • Oncology
  • Pharmacology

Background:

  • Cancer chemotherapy, particularly moderately and highly emetogenic regimens, poses a significant challenge due to side effects like nausea and vomiting.
  • Effective management of chemotherapy-induced nausea and vomiting (CINV) is crucial for patient quality of life and treatment adherence.

Framework:

  • This review focuses on antiemetic therapy for chemotherapy administered over several days per cycle.
  • The discussion encompasses both prophylactic (preventive) and therapeutic (rescue) antiemetic approaches.

Implementation:

  • Evaluation of the most efficacious antiemetic strategies tailored to specific chemotherapy regimens.
  • Consideration of the timing and combination of antiemetic agents for optimal control.

Implications:

Related Experiment Videos

  • Improved patient outcomes through better control of CINV.
  • Enhanced patient tolerance of cancer chemotherapy, potentially allowing for dose escalation or continuation of treatment.
  • Guidance for clinicians in selecting appropriate antiemetic regimens for complex chemotherapy protocols.